initial public offerings (IPOs) trading on American exchanges
Showing posts with label VIK. Show all posts
Showing posts with label VIK. Show all posts

Monday, May 27, 2024

IPOs this week : May 27 - 31, 24 (wk 22)

IPOs expected to price
No new IPOs are anticipated to launch in the week ahead. 

IPO quiet period expirations
  • The quiet period ends on Viking Holdings (VIK) to free up analysts to post ratings. 

Viking and Ibotta (IBTA) will also release their first earnings reports as publicly traded companies.

Tuesday, May 7, 2024

Viking Holdings (VIK) began trading on the NYSE on Wed 1 May 24

Viking Holdings Ltd engages in the passenger shipping and other forms of passenger transport in North America, the United Kingdom, and internationally.
As of December 31, 2023, it operated a fleet of 92 ships, including 81 river vessels comprising 58 Longships, 10 smaller classes based on the Longship design, 11 other river vessels, and 1 river vessel charter and the Viking Mississippi; 9 ocean ships; and 2 expedition ships.
  • Sector: Consumer Cyclical
  • Industry: Travel Services
  • Full Time Employees: 9,500
  • Founded in 1997
  • Based in Pembroke, Bermuda.
  • https://www.viking.com
Viking Holdings priced 64,041,668 share IPO at $24.00 per share, at the higher end of the $21-25 expected range.
Ticker: VIK
 


 

Monday, April 29, 2024

IPOs this week : Apr 29 - May 3, 24 (wk 18)

IPOs expected to price
  • Viking Holdings (VIK): The ocean and river cruise company is planning to sell 44M shares priced between $21 and $25 per share in an initial public offering. The company disclosed in an SEC filing that in 2023 it reported a loss of $1.85B on $4.7B in revenue as cruise operating expenses increased by 33% to $2.85B. Adjusted EBITDA loss widened to $1.09B from $367M in 2022 and the adjusted EBITDA margin expanded to 35.5% from 18.4% the year prior. Viking started in 1997 with just 4 river cruise ships but has expanded to 84 ships in operation with 650K passengers in 2023. 
IPO quiet period expirations
  • Contineum Therapeutics (CTNM) and 
  • Massimo Group (MAMO

IPO lockup expirations
  • Alpha Technology Group (ATGL) and 
  • Lexeo Therapeutics (LXEO).